Lv3
348 积分 2022-09-04 加入
Discovery of Selective and Potent Macrocyclic CDK9 Inhibitors for the Treatment of Osimertinib-Resistant Non-Small-Cell Lung Cancer
1个月前
已完结
Development of a mono‐specific anti‐VEGF bivalent nanobody with extended plasma half‐life for treatment of pathologic neovascularization
2个月前
已完结
Genetically engineered red cells expressing single domain camelid antibodies confer long-term protection against botulinum neurotoxin
2个月前
已完结
Fenobody: A Ferritin-Displayed Nanobody with High Apparent Affinity and Half-Life Extension
2个月前
已完结
Albumin-binding domain from Streptococcus zooepidemicus protein Zag as a novel strategy to improve the half-life of therapeutic proteins
2个月前
已完结
Reduced elimination of IgG antibodies by engineering the variable region
2个月前
已完结
ELPylated anti‐human TNF therapeutic single‐domain antibodies for prevention of lethal septic shock
2个月前
已完结
A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner
2个月前
已完结
Development of a novel nano-sized anti-VEGFA nanobody with enhanced physicochemical and pharmacokinetic properties
2个月前
已完结
Reduced elimination of IgG antibodies by engineering the variable region
2个月前
已完结
皖公网安备34019202002308
